752-6102-00L


L. T.
This flashcard set delves into the intricate relationship between food, nutrition, and disease prevention at a university level, focusing on key factors like protein intake, vitamin D, calcium, and their effects on musculoskeletal health. It explores how different nutrients influence disease risk, particularly in conditions like osteoporosis and sarcopenia, and discusses preventive strategies. This set is invaluable for students and healthcare professionals aiming to understand how dietary choices impact long-term health and disease management.
Karten
68
Lernende
1
Sprache
Englisch
Kategorie
Biologie
Stufe
Universität
Erstellt / Aktualisiert
07.03.2021 / 11.06.2021

Lernkarten

Nutrition and Brain, Baumgartner

Explain the role of macro and micronutrients in the brain

  • Give examples of some important micronutrients
  • Vulnerability to nutrient deficiency: what do studies need to consider?
  • how are microbiome and brain development related to one another?

Overall metabolism

  • brain highly metabolically active --> 60% of O2 consumption of child vs 20% adult
  • relies on many different nutrients for growth, repair, function
  • overall, brain's dry matter made up of
    • 60% fat
    • 20% CHO
    • 10% proteins

Vulnerability to nutrient deficiency

  • depends on timing and duration of deficiency --> short-term folate deficiency during conception much more dangerous than short-term folate deficiency postnatal
  • brains requirements, which change depending on developmental stage --> omega-3 FA necessary during breastfeeding period
  • study investigating the behavioral changes due to deficiencies must be designed properly:
    • what area is affected by the deficiency --> what function altered
    • when does the specific area develop --> when did deficiency occur or when is supplementation likely to show positive effects
      • eg: assing problem-solving skills in toddlers makes no sense, because area not fully developed at that time
    • dose/degree of deficiency --> may only cause harm at severe deficiencies --> pregnant mother can maintain normal TH despite mild iodine deficiencies, but severe deficiency causes cretinism

Folate

  • essential for proper formation of neural tube
  • important before and during conception, because neural tube formed at day 22

Iodine

  • Thyroid hormones important for neuronal migration, proliferation, and myelination --> fetus relies on maternal TH transfer up to 3rd TM
  • severe iodine deficiency results in cretinism --> important that fetus can stock up iodine

Omega-3 LCPUFA

  • make up largest part of fats found in brain (50-60%)
  • mostly DHA --> EPA can affect brain via peripheral mechanisms: modulation of sysntemic inflammation and vascular health
  • proportions and accrual of n-3 FA
    • switch in n-6/3 content in brain: up to 10y, ARA content > DHA --> stabilizes in adulthood
    • increase in DHA 35x from 30wk to 18 motnhs --> importance of mother's milk

Microbiome

  • development in offrping's microbiome coincides with brain development --> in line with brain-gut-axis-hypothesis
  • early life nutrition may affect microbiota and brain directly and indirectly due to the existing interactions between them

Nutrition and Brain, Baumgartner

  • fundamental questions & key concepts
    • which concepts need to be clear in regards to timing and the relation between nutrients & brain development?
    • what key concepts need to be considered: study design, timing of intervention, tools used...

Fundamental questions

  • Matching: does nutrient affect cognition/behavior beyond sheer brain development?
    • how strong is the relationship?
      • for nutrient(s) --> additive or interactive effects with other nutrients/environment?
      • for given timeframe, e.g. first trimester
  • Are the consequences of a deficiency long-term or short-term?
    • short-term: acute dysfunction
    • long-term: cognitive development delayed/hampered

Key concepts

  • Matching (see above)
  • proper tools
    • to assess deciciency per se as well as impact it has on cognitive domains
  • child age: early testing possible, but more reliable as child ages
  • study design
    • rct vs interventional
    • sample size

Nutrition and Brain, Baumgartner

  • What are the 3 types of tools used to study nutrition and brain development in children?
  • what are the strength and limitations?

Approaches to measuring cognition in humans

  • Cognition: involves many different factors, such as
    • language/psychomotor/perception/attention/memory/executive functions (vgl Bild)
  • Global measures: IQ,
    • usually paper-based, otherwise PC-based
      • motor and language based tests for infants
    • limitations
      • widley applied but limited sensitivity due to global assessment of cognitive function --> score difficult to relate to nutrient deficiency
      • timing
        • must be timed properly --> difficulty of test must be appropriate to child's developmental stage
        • may overlook long-term effects when short-term effects are not present
      • high intra and interindividual variability
        • child can be distracted in room or by assessor
  • Domain specific testing
    • test battery that assesses a given cognitive domain that is hypothesized to be affected by a nutrient deficiency at a given time point of development
    • must be sensitive enough for intervention duration
    • has replaced global testing because of higher specificity
    • cultural differences may turn questions more difficult to certain child group --> cultural fairness
    • requires validation
      • does the test depict cognitive domain of interest + does nutrient intervention affect domain of interest?
  • Neurophysiological tools
    • MRI and fMRI measure brain anatomy and function, repsectively
    • EEG: evoked potential of different stimuli can be assessed
    • NIRS, non-invasive and suitable for field
    • strengths & limitations
      • (-): expensive, not suitable for field, expertise required
      • (+): can be used during sleep, very sensitive thereby useful to clarify discrepant findings, potentially smaller sample sizes than with traditional assessment tools

Nutrition and Brain, Baumgartner

Iron

  • how distributed in brain?
  • what functions does it take on on brain?
    • what if deciciencies occur?
  • what evidence available?
    • hint: Nepal

Iron and brain development

  • Iron distribution in brain
    • age specific: accumulates over time up to age 40
      • highly present in areas undergoing myelinisation during development
    • area-, cell-specific: involved in neurotransmission of dopmainergic areas
  • Iron function in brain
    • oxygen transport to brain --> high O2 needs
    • energy production in cytochormes in mitochondria
    • NT synthesis: dopamine synthesis is Fe-dependent
    • myelinisation: Fe used as co-factor of enzymes reponsible for myelinisation as well as FAs
      • deficiency: myelin content and quality (via FA) affected --> transition speed affected in children
  • Iron deficiency
    • crucial for myelination in 3 TM as well as up to age 3 --> deficiencies irriversible long-term damage
      • slow speed of processing and synaptic efficiency
      • spatial memory and learning affected
      • poor school achievement, attention, memory, language development, motor skills and socioemotional development --> child prone to health and psychological chalenges in later life
        • on large scale, poor development results in poverty of a nation
  • Evidence
    • Nepal study: Fe & B9 during pregnancy until 12 months postpartum results in better cognitive outcomes and motorcontrol than placebo group
      • prolonging supplementation from 12 to 36 motnhs shows no additional benefit --> time-window pre/perinatal
    • deficiency as well as anemia can lead to short and long-term consequences on congitive, motor and socioemotional domains
      • short term: O2 supply to brain insufficient?
      • long term: neurological deficits due to hampered myelination
    • anemic school children benefit from supplementation --> example of short term negative consequence

Nutrition and Brain, Baumgartner

Omega-3

  • what effects do n-3 FA have on
    • brain development & structure
    • brain function
  • how do different LCPUFAs contribute to brian health?
  • what are known consequences of LCPUFAs deficiencies?
  • what is the evidence on LCPUFAs intake during pregnancy and childhood?

Omega-3 LCPUFA

  • make up largest part of fats found in brain (50-60%)
  • mostly DHA --> EPA can affect brain via peripheral mechanisms: modulation of sysntemic inflammation and vascular health
  • proportions and accrual of n-3 FA
    • switch in n-6/3 content in brain: up to 10y, ARA content > DHA --> stabilizes in adulthood
    • increase in DHA 35x from 30wk to 18 motnhs --> importance of mother's milk
  • affect brain function
    • via membrane fluidity --> receptor affinity in synapses increased
    • some n-3 FA used as fuel source --> brain requires lots of E
    • indirectly: attenuate inflammation and modulate IS via gene expression
  • LCPUFA deficiency
    • altered FA profile
    • processing speed of visual cues affected
    • during perinatal period, animal model
      • myelinisation, synaptogenesis and neural membran FA composition affected
    • reductions inf brain glucose uptake and metabolism
  • Evidence
    • oberservational studies of seafood intake: beneficial effect when consumed during pregnancy as well as childhood
      • cannot establish causal relation due to nature of study
    • intervention studies of omega-3 supplementation: no effects and inconclusive results

Intro lecture Baumgartner

Prevention and treatment

  • what factors are important to prioritize treatment and prevention?
  • wat are modifiable risk factors?
  • how is health captured, name two important factors reflecting health of a population

Prevention and treatmentent

  • Prioritizing of efforts necessary, but this requires knowledge about risk factors, stats and evidence
  • (modifiable) risk factors
    • smoking
    • phyical inactivity
    • alcohol abuse
    • unhelthy diet
  • statistics and evidence help to identifiy most important health problems as well as solutions to it
    • Global Burden of Disease study:
      • ongoing study in entire world since 1990
      • captures data on incidence, prevalence and mortality of different conditions causing premature death or disability
        • incidence: number of new cases
        • prevalence: number of existing cases at/during a given timepoint/period
      • mortality and morbidity can be extrapolated
      • published in the LANCET: continuous epidemiological data on development of many NCDs
    • population health summary measures --> not applicable to single individuals!
      • HALE: healthy life expectancy
        • compares healthspan with lifespan --> number of years to be lived in full health
        • increases if
          • risk factors are reduced
          • healtcare quality improves
        • decreases if (e.g. gap between HALE and lifespan increase)
          • with age --> usually #1 risk factor for NCDs
      • DALY: disability adjusted life years
        • sums life years lived with disability & non-fatal disease and compares to standard, normative mean of expecte life years --> basically how many years of theoretical maximum are cut short due to illness
        • time-based
        • uses factor to adjust for severity of different diseases experienced
          • not always clear where to draw line betwen healthy and unhealthy
          • death always more impactful on daly than disability/disease
        • metabolic factors make up large part of DALYs
      • DALY and HALEs allow to
        • assess burden of disease as well as efficacy of health system performance
        • target investments

 

 

Intro Baumgartner

NCDs

  • definition
  • trend worldwide
  • costs

Non-communicable diseases

  • global trend for NCDs is increasing while communicable, neonatal and maternal diseases decrease
    • injuries remain indifferent
  • affect men and women to same degree
  • costs: high because ncds are chronic diseases
    • usually remain for a lifetime or difficult to reverse (obesity, cancer)
    • expensive medication and treatment (antibiotics or other medication against communicable diseases less expensive)

Intro lecture Baumgartner

  • Explain epidemiological transition

Epidemiological shift

  • improvement in hygene, reduction in childhood mortality and healthcare improve --> mosrtality decreases --> demographics: more aged individuals --> higher NCD risk
  • shift from traditional foods to Westernized diet --> obesity and chronic diseases as well as chronic burden of malnutrition increase

Intro lecture Baumgartner

  • explain Fetal Origins of Adult Disease

  • discovery of increase prevalence of NCDs in men stemming from areas where childhood mortality was higher
  • low birth weight = proxy for poor prenatal nutrition --> associated with T2D, CVD & high bp
  • first 1000d as key timeperiod for health
    • high plasticity --> can backfire in case of maternal malnutrition due to (epigenetic) imprinting
    • evidence on humans almost impossible to obtain due to duration, but evidence from animals available

Costs of chronic diet-related diseases in Siwtzerland, Wieser

  • explain three main dimensions of disease cost
    • how do these dimensions look in CH, how have they changed and which ones are the most important ones
    • how are these dimensions assessed/established?

Direct medical costs

  • monetary value
  • ressources others have to invest in order to cure/take care of diseased person
    • can extend to family and non-professionals/non-medical persons
  • in CH: healthcare
    • about 1/3 of of illness-related expenses amount to healtcare in CH
      • 9730.- Fr/y per capita
      • in CH costs are high but when adjusted for purchasing power, expenses become 20% higher (and more realistic) as opposed to 50% difference in absolute means

Production losses

  • of the person affected
  • also measured in monetary fashion --> usually based on salary of individual x time
  • different types of production loss
    • partial loss: absenteeism (some weeks/months) or presneteeism (reduced workload/pensum)
    • total loss: permanent disability or death
    • potential loss: suboptimal development and cognitive weknesses, e.g. LMIC with stunting/nutrient deficiencies
  • how to measure production losses
    • questionnaires to capture how often/long employers absent/reduced workload
    • administrative data to assess partial or total disability
    • epidemiological data for premature mortality
      • additionally impared physical and cognitive development in LMIC
  • production losses in CH
    • mental and musculoskeletal disorders have greatest impact --> chronic and very low mortality cause long absence
      • more "deadly" NCDs have comparable low impact, but also because mortality higher

DALYs

  • disability and loss in quality of life measured in DALYs, not monetary
  • DALY two components: time and weight of disease
    • YLD: years lived with disability --> non lethal but disabling condition
    • YLL: years of life lost
  • severity reflect by DALY weight and must be defined --> worldwide questionnaires
    • chornic diseases realtively low weight
    • mental diseases and pain high weight
    • good correlation between different cultures shows agreement on severity of different conditions
  • In CH
    • neoplass responsible for large part of YLL
    • musculoskeletal diseases for YLD --> larger impact than YLL, typical for country with good healthcare system
    • DALY burden has  declined by about 30% in last 30 years --> big progress

Costs of chronic diet-related diseases in Siwtzerland, Wieser

Give an overview of the current knowledge on costs in CH

  • by what categories can the data be visualized?
    • what are the major causes of disease burden for these categories?
    • what costs are not included
    • how was GBD study used in this particular case?

Dimensions of healthcare costs in CH

  • by service
  • by type of service provider
  • by type of financing instance
  • by illness and disease
    • defined using the GBD study
      • costs for pregnancy, aesthetics and similar not included
      • co-morbidities separated

Enteral and Parenteral Nutrition Meier

  • Malnutrition
    • what is the importance of oral nutrition therapy in regards to malnutrition?
      • how's the situation in hospitals?
    • prevalence
      • WW & CH
      • who's most commonly affected?
    • procedures to identify malnutrition
      • what are signs

Malnutrition

  • Importance of oral nutritional therapy
    • prevalence of malnutrition increases during hospital stay (vgl Bild: nutritiona lstatus deteriorates...)
      • 55% of served food returned --> flight attendant experiment
    • affects therapy outcome and mortality
      • improving nutrition during hospital stay is economic
      • daily requirements of many nutrients not met, depending on which requirements chosen, 53-70% --> nutrition in hospital setting is highly insufficient
  • Reasons for malnutrition (kennste)
    • Clinical: Nausea, Cancer, infections, low BMI --> can affect hunger and appetite hormones
    • Non-clinical
      • mastication problems
      • monotonous food
      • food temperature & serving times
  • Identification of patients at risk of malnutritoin or suffering from malnutrition
    • high risk patients: low BMI, disease-related weight loss
    • geriatric and oncology most commonly affected
  • procedure of malnutritoin identification
    • Risk screening
      • using screening tools: NRS 2002
    • Diagnostic assessment
      • phenotypic: low FFM measured via DXA/BIA, unintentional weight-loss
      • etiologic: low food intake, disase-related difficulties eating
    • Diagnosis
      • at least one phenotypical and one etiological criterion
    • Severity Grading
      • moderate --> vgl Bild
      • severe --> BMI<18.5, NRS >= 3, >10% weight loss in past 6m, serum albumin < 30g/l
  • prevalence
    • worldwide about 25%, same for CH

Enteral and Parenteral Nutrition Meier

Parenteral Nutrition

Parenteral Nutrition

  • indications
    • access to stomach blocked
      • anatomical reasons: cancer
      • gut dysfunctional: perforation, obstruction...
    • tube feeding unsafe
      • excessive vomiting: pregnant women
    • patients who require bowel rest
      • acute gastroenteritis, radiation etheropathy, high output fistulas
    • major clinical indications
      • Acute and critically ill patients
      • Post acute patients (eg after surgery)
      • Pre operative malnutrition
      • Home parenteral nutrition (eg short bowel)
  • contraindications
    • gastrointestinal tract fully operational
    • no access to veins (vena subclavia most common)
  • Delivery systems
    • bags/containers with different nutrients that can easily be mixed
      • All in one options also available
    • Home parenteral nutrition
      • for chronic intestinal failure
      • short bowel syndrome or Crohn's
      • cancer patients with intestinal failure --> most common
  • must take present and future into account: assure safety and nutritional balance for existing benign condition (ex short bowel) + prevent future complications related to nutrition
  • will affect QoL and may become unsuited in an unpredictable time span due to laignant comorbidities
  • complications often occur in PN and can be reduced via monitoring
    • metabolic
      • Refeeding syndrome
      • Hyperglycaemia and hypoglycaemia
      • Hypertriglyceridaemia
      • Hepato biliary complications (HPN)
      • PN induced bone disease (HPN)
    • technical
      • early: pneumothorax, bleeding
      • late: vein thrombosis
    • infections --> local can develop to systemic
    • monitoring
      • anthropos: monitor weight, arm cicrumferences, BIA --> indicator for muscle mass
      • funtion: check hand grip strength
        • lab results of bioechical, haematological, microbiological values

Enteral and Parenteral Nutrition Meier

Enteral Nutrition

Nasogastric/enteral tube (enteral nutrition, EN)

  • main goal: treat malnutrition and improve outcome
  • performed if foods intake in coming 7 days anticipated to be insufficient or if malnutrition diagnosed
    • ethical consideration: EN must improve QoL --> if it prolongs suffering of a dying patient, it is unethical
    • prior to insertion of tube, expected benefit must be considered
  • contraindications
    • gastrointestinal issues: obstruction of intestines + others (vgl Bild)
    • circulatory: schock, cardiac insufficiency
    • metabolic: coma, ketoacidosis (diabetes)
  • Different accesses types for different durations
    • nasogastric & nasojejunal
      • short term less than 30d --> longer periods via parenteral or special types of enteral
    •  percutaneous endoscopic gastrostomy: PEG, PEG-J, D-PEG
      • access to stomach via inserted tube --> food injected into stomach with seringe (Dave having lunch)
  • Complications
    • reflux
    • infections
    • malpositioning of tube in brain or lung
    • refeeding syndrome: reintroduction of food results in ATP generation, yet micronutrient deficiencies limit many biochemical processed so that organism is overtaxed putting the individual in a life threatening situation

Enteral and Parenteral Nutrition Meier

ONS

  • Evidence: top or flop?
  • what types exist and when are they do be used?

Oral Nutritional Supplements

  • first line adjuvant nutritional therapy
  • different types
    • polymeric: entire foods, commercially available --> usually better tolerated and used most often
    • oligomeric: broken down macros --> peptides & micro's
    • disease specific: diabetes, CKD...
    • isolated macros
  • Forticifaction of foods first step of malnutrition treatment, further step taken with sip feeds if fotification insufficient
  • concinving evidence for the effectiveness of ONS in the clinical setting (multiple meta-analyses)

Enteral and Parenteral Nutrition Meier

Oral Nutrition Hospital

Oral Nutrition Hospital

  • special types of criteria to adapt nutrition to patient
    • protein requirements can differ between patient groups
      • restricted: e.g. renal insufficiency
      • elevated: e.g. dialysis patients
    • Energy
      • elevated: malnutrition
      • restricted: obesity
    • medical indications
      • gastroenterogical: gluten free, lactose free...
      • speicial conditions: frc free, germ reduced, phenyl-alanine free
  • Protected Mealtime Policy
    • assistance for people who need help (paralysis, e.g.)
    • give patients enough time to consume meal -->no doctors or nurses present
    • in between snacks to increase kcal intake
  • Monitoring of food intake via supervisisoin of tray collection

Infant and young child feeding, Baumgartner

Breastfeeing practices

  • what is the rationale for breastfeeding
  • what are short and long-term effects on breastfeeding
    • on child --> name 3 main domains, then exemplify
    • on mother
  • possible mechanisms mediating the above effects

Breastfeeding practices

  • Timing
    • within one hour of birth
    • until up to age 2 or even beyond, on-demand
  • exclusive breastfeeding for first 6 months
    • HIC: introduction of complemetary foods as of fifth month recommended
  • rationale
    • no adverse outcomes on growth & natural (mother’s milk much more complex and rich in diverse nutrients/bioactives than formulas)
    • short-term (infancy)
      • decreased newborn mortality --> protects against diarrheal and pneumonic infections
        • sudden-infant-death syndrome (SIDS)--> two months reduce risk by 50%, longer breastfeeding further reduces risk of SIDS
        • compared to non/partially breastfed children: not breastfeeding increases infection-realted mortality 2x
      • beneficial effect on gut health --> necrotisation of enterocolitis prevented in pre-term infants
    • long-term (later life)
      • protective against neurodevelopmental delays
        • potential enhancement of motor development
      • protective against metabolic diseases (hypertension, diabetes, obesity)
      • protective against immune-related diseases (allergies, coeliac, IBS)
        • WHO meta-analysis: non or sporadically breastfed children prone to develop obesity whereas breastfeeding for at least 6 months protects children
      • Protective effect possibly mediated but gut microbiome modulation during first 1000d
        • Microbiota of breastfed infants differs from formula fed à more commensal, less pathogenic strains
      • Protective effects also for mother à diabetes, obesity, breast/ovarian cancer

Infant and young child feeding, Baumgartner

Complementary feeding practices

  • what importance of complementary feeding, what is the goal?
    • what if complementary feeding fails?
  • what foods shoould be consumed
    • amounts
    • rythm
    • type
    • foods to avoid
  • how many children get appropriate complementary feeding worldwide?
  • important aspects of compl. feeding during illness
  • explain:
    • responsive feeding
    • early protein hypothesis

Complementary feeding practices

  • necessary to cover increased needs as of 6 motnhs that cannot be covered by mother's milk anymore
    • sub-oprtimal complementary feeding à stunting
  • complementary foods (= first foods)
    • semi-solid and soft
    • complement mother's milk --> closes the gap between requirements covered by milk and requirements milk cannot cover but that the growing infant has
    • from month 6 to 23 --> some children ready earlier, around 4 months
    • 70% children WW are introduced to first foods, but only 20% with minimum diversity and frequency à breastfeeding from 12-23 months persists in 65% of cases WW
  • weaning: stopping breastfeeding and switching over to semi-solid foods
  • complemenary feeding practices & recommendations
    • quality of foods important:
      • ensure food variety by feeding at least 5/8 food groups
        • animal foods incl. mother’s milk
        • fruits & veggies
      • avoid empty calories --> high nutrient density foods important
      • Portion sizes: start with small portions, soft and little variety and 2-3 meals per day
      • Variety increase variety, volume and frequency of feeding
    • other important aspects & special situations
      • hygiene & proper food handling
      • use fortified foods if necessary
      • in case of illness --> increase drinking volume and offer favorite foods to ensure proper food intake
    • responsive feeding: watch out for and respect child’s reaction to feeding à foundation of (good) eating habits
    • early protein hypothesis: protein intake > protein requirements primes metabolism to become obese

Infant and young child feeding, Baumgartner

DOHaD

  • explain framework --> draw!
  • hints
    • environment
    • early nutrition
    • adult health & disease

DOHaD Framework

  • environmental stressors prime organism à organism becomes prone to diseases if environment changes / is not-well prepared to environment
    • genetic
    • epigenetics
      • DNA
      • Histone
      • Chromatin structure
      • miRNA
  • trajectories in early life more modulable/plastic, relatively low effort and pronounced impact on later life
    • little known on how breastfeeding and complementary feeding affect epigenetics and microbiota
      • obesity incidence more strongly correlated with microbiome at 3 months than at 12 months
    • partial breastfeeding with additional formula à microbiota more similar to formula-fed infants
    • breastfeeding/mother’s milk has epigenetic effects
  • epigenome and microbiome interact with phenotype and early nutrition à 1000d for microbiota modulation

Eating disorders, Milos

Definitions

  • General characteristics of eating diorders
  • three types of eating disorders
    • prevalence
  • common co-morbidities
    • mortality

 

Risks and complications of eating disorders

  • Types
    • Anorexia nervosa (AN)
      • typical symptoms: worry about body shape, self-esteem linked to weight/appearance, fear of gaining weight
      • 1.2% women
      • weight 15% below expectation
      • BMI < 17.5 kg/m2
      • weight loss caused by active or non-active measures
        • active: vomiting, laxatives
        • non-active. eating-restriction
      • always a behavioral and psychologic features
    • Bulimia nervosa (BN)
      • typical symptoms (same as AN): worry about body shape, self-esteem linked to weight/appearance, fear of gaining weight
      • normal weight, but preoccupation with weight --> self-esteem related to weight
      • high food intake due to food attacks --> 1/week
      • vomiting to compensate for food attacks
    • Binge eating
      • food intake >>> during at least 3 months
      • characteristic behavior: fast and abnormally bulky food intake despite absence of hunger followed by disgust and guilt
  • Characteristics
    • often slowly and gradually developing bnormal eating behavior with tendency of becoming chronic
    • eating disorder is hidden from family/friends and third parties
    • profound impact on life: physical, psychological, professional, and social
  • Co-morbidities
    • mostly psychatric nature
      • high rates of suicidal tendencies amongst eating disorders
      • difficulties to assess own and other's emotions
      • difficulties to see big picture, obsessive with details
    • mortality in anorexic people ~6%
    • hormonal foundation: leptin-like effect observed in AN
      • increased activation of HPA and HPG (gonads) axes --> reduced BMD, increased physical activity but also reduced reproductive activity
    • organ specific --> vgl Bild
      • gastric emptying
      • osteoporosis --> 40% of patients have low BMD
      • amenorrhea --> fertility affected
      • cortical brain atrophy

Eating disorders, Milos

Etiology & Therapy

  • name three main areas of etiology and exemplify each
  • give an overview of therapy
    • who is involved?
    • who is targeted?
    • what are the main goals of therapy?

Multifactorial etiology

  • Biological and genetic factors
    • genome-wide association found 8 loci involved in AN
    • pre- and perinatal factors:
      • infections during pregnancy
      • SGA
      • birth complications
      • feeding disorders in infant
      • childhood: obsessive, perfectionistic behavior
    • Neuro
      • alteratino in the dopaminergic system leads to self-starvation becoming a trigger of motivation --> viscous cicle
  • Personality and individual experiences
    • Character traits
      • low self-esteem
      • obsessiveness
      • anxiety
      • emotional inhibition
    • trauma
      • sexual abuse or other trauma
      • strict diets in family
      • critical experiences towards appearance/weight/eating
  • Socio-cultural factors
    • beauty standards
      • fashion standard
    • overabundance of food
    • unhealthy role models

Therapy

  • interdisciplinary --> communication is key!
    • medical entities (family physician, specialists, gynecologists, dentists, internal medicine)
    • employer
    • social services
    • psychiatry
  • target patients as well as patient's surrounding
    • get insight and enhance trust, and motivate change
    • family, relationship
    • work
  • major goals
    • reach at least BMI = 18.5 or stabilize weight if normal BMI
    • normalize eating habits --> 3 meals/d with 2-3 snacks
    • treat comorbidities (somatic/psychiatric)

Musculoskeletal diseases and nutrition, Andersson

Bone basics

  • bone homeostasis
    • renewal duration
    • BMD pattern throughout life --> draw
      • same for all?

 

 

Bone homeostasis

  • Bone basics
    • trabecular: 15.25% calcified
    • cortical bone: 80-90% calcified,
    • cells
      • osteoblasts & osteoclasts: build/resorb bone
      • osteocytes: derive form osteoblasts and represent mature cell, 80-90% of bone
  • renewal every 10 years
  • peak bone mass between age 30 and 40
    • gender differences:
      • women have lower BMD to begin with --> 60-80% genetically inherited, rest modulated by environment
      • menopause-caused fall in estrogen results in greater bone resorbtion and therefore lower BMD in females

Musculoskeletal diseases and nutrition, Andersson

  • Osteoporosis
    • prevalence --> how many falls
    • burden of fractures
    • risk of fracture depending on first/seonc fracture and gender
    • how measured/proxy
    • reatment and preventive strategies

 

Osteoporosis

  • loss of bone mass (quantity) and deterioration of bone archtecture (quality)
  • consequences
    • greater fracture risk
      • most commonly spine, hip or wrist fractured
      • 5-6% of falls actually result in fracture
    • collapsed vertebra --> tooped posture
  • prevalence
    • gender differences --> 20% females, but also 5% males affected
    • worldwide variance in prevalence assumed to have genetic reason, not nutritional
    • 75% of osteoporotic fractures in >70 year-olds
    • risk for first fracture differs between gender (50% or more for females vs 20% males), but not for second fracture: 20% both gender
      • risk for second fracture highest in the year following the first fracture
  • cost & disease burden
    • 13'000€/hospitalization --> greater than cancer, heart, and stroke combined due to greater prevalence of osteoporosis fractures than other
  • link to sarkopenia
    • fear of falling reduces mobility and thereby muscle mass --> ultimately increases fall risks
    • muscle strength correlates with BMD

Musculoskeletal diseases and nutrition, Andersson

Sarkopenia

  • prevalence
  • consequences
  • etiology
  • risk factors

Sarcopenia

  • prevalence: 20-75%, depending on population and source of information
  • consequences
    • poor hospital outcomes, risk of falls, loss of independence
  • definition and diagnosis not always clear --> muscle mass measurements, handgrip strength
  • muscle strength via handgrip
    • peak in early adulthood
    • bi-phasic decline --> gradual as of age 40, substantial as of age 50
  • etiology
    • systemic inflammation
    • ageing-associated processes
      • reduced autophagy
      • loss of mitochondria with additional decline in mitochondrial function
      • impared stem cell regeneration
    • los protein intake and negative protein turnover --> decrease in MyoPS and MitoPS
  • Risk factors
    • sarcopenic obesity
    • extreme weight loss
    • drugs & pharmacological therapy --> ACE inhibitors
    • smoking & alcohol
    • sedentariness
    • genetic/intrsinsic factors: gender, sex hormone deficiency, comorbidities
  • Prevention
    • sarcopenia considered to be a nutritional disorder
    • lifestyle interventions effective
      • exercise: less conclusive evidence
      • nutrition: evidence more equivocal and in favor of greater protein intakes
    • pharmacological treatments use hormone replacement --> testo / SARMs

Musculoskeletal diseases and nutrition, Andersson

Osteoporosis

  • Risk factors
    • what clinical RF exist?
  • Screening
    • typical tool used
    • cut-off values
    • how do informatics play a role in risk assessment? Exemplify!
  • What typical areas of body fractured?

 

Risk assessment

  • Risk factors
    • clinical --> vgl Bild
    • BMT-D score --> assessed using DXA
      • < -1 SD: osteopenia
      • <= -2.5 SD: osteoporosis
      • <= -3 SD: severe osteoporosis
    • BMD is integrated into the FRAX algorithm  (fracture risk assessment tool) with clinical risk factors to predict 10-y risk for certain fractures
    • sometimes no BMD assessemtn available (e.g. men or subsequent to typical fracture) --> recommended treatment if:
      • FRAX risk > treshold (country specific)
      • fracture of hip, vertebrae, proximal humerus, pelvis, distal arm
  • who to screen
    • essentially, screening is recommended to postmenopausal women, especially >65y 
    • men >70 recommended to screen depending on Consensus/Foundation

Musculoskeletal diseases and nutrition, Andersson

Calcium

  • requirements increase slightly after 50y from 800 to 1000 mg/d
  • recommendations
    • 800-1200 mg/d
    • foods preferred source
    • addition of vitamin D in institutionalized individuals
  • calcium rich foods: mostly dairy and animal-based, although present in many fruits and vegetables too
    • average intake in Western 700-900 mg/d
    • dairy product effective in preventing the decline of BMD, but not in its restauration
      • under debate: evidence for persisting bone loss in postmenopausal women despite intakes of Ca of 300 - 2000 mg/d
  • supplements
    • supplements sometimes necessary to meet recommendations --> 30-50% of older women in western countries prescribed supplements
    • uptake kinetics between dairy and supplemental Ca differs
      • supplements peak vs dairy plateaus --> potential mechanism for vascular complications, but not yet clearly identified
  • Evidence
    • may increase risk of vascular diseases
    • inconsistent results on fracture reduction (meta-analysis)
      • reduction total fractures and vertebral fractures but not forearm or hip
      • often supplementes combined with vitamin D --> no additional effect
      • overall: no convincing evidence and, if any beneficial effects of Ca on BMD, then only minor
    • increased BMD by 1% after 1y --> not cost-effective

Musculoskeletal diseases and nutrition, Andersson

Vitamin D & risk of fractures and falls

  • what is the recommended dosing
  • deficiency
    • what is special about cut-off values?
    • compare different regions: Northern EU vs rest of EU vs middle east
  • evidence
    • inconsitsent findings: why?
    • what is still recommended
    • who is liekly to benefit?

Vitamin D

  • deficiency
    • serum 25(OH)-D best marker for Vit D status
    • disagreement regarding cut-off values but unanimity that <25 nmol/l severe deficiency
    • values <50 nmol/l increase from Northern Europe to Western/Southern/Eastern Eruope and up to 80% of individuals deficient in Middle East --> more sun not necessarily more Vit D
  • Evidence
    • link to muscle function
      • mechanistic
        • muscle has vit-D-receptor (VDR) and converts it to 25OH-D --> supplementation increases VDR expression
        • deficiency affects mostly type 2 fibers
      • lower strength & functional decline in vit D deficient individuals observed in observational studies
      • supplementation shows reduced fall incidence
    • Lancet meta-analysis suggests no benefit of vit D supplementation to decrease fall incidence
      • negligable effect on vit D vs control as well as high vs low dose
      • small effect on selected populations (es = 0.83)
      • critiqued by mani experts in the field
        • biased study selection: no studies of vit D an calcium --> 40% of high quality data not included in meta-analysis
        • deffectiveness of daily dose of 800-1000 IU well established
    • Dosing
      • 2000 IU no effect on fall and fracture incidence
        • DO-HEALTH
        • doses of 20'000 IU/d for prolonged period may increase risk of falls
      • 800 IU usual recommendation to at-risk population (elderly and little exposure to sunlight)
      • >4000 IU not recommended, unless malabsorbtion
  • Supplementation & approach
    • in case of deficiency, supplementation is required and likely to reduce risk of falls
    • replete individuals are unlikely to benefit from supplementation

Musculoskeletal diseases and nutrition, Andersson

Protein

  • intake recommendations
  • evidence on protein intakes and bone health (not muscle!)
    • how do types differ?
    • what are the advantages and disadvantages of greater protein intakes?

Protein

  • 1.2-1.5 g/kg/d to overcome anabolic resistance --> often unfeasible due to lack of appetite, too much food, mastication problems...
    • 25-30g protein per meal required
  • Evidence for protein & bone health
    • moderate evidence: protein with Ca and vit D might improve BMD and
    • amount: higher protein intakes are generally better than low in terms of bone health --> no effects on bone biomarkers
      • meta-analysis across life-course shows different result depending on data used
        • non-adjusted: greater protein intake associated with better bone health
        • covariate adjusted: no association between amount or type of protein and fractures
    • higher protein intakes have at least no deleterious effects
    • type: soy and animal-based protein seem indifferent in terms of how they affect bone health

Lernen